George Butler

George Butler

SingEval Management Team

George Butler, PhD

CEO SingEval Inc

Previous VP Regulatory Affairs AstraZeneca, 30 years development experience on a global basis in ‘big pharma’.

Dr. Butler has over 30 years of healthcare research and business experience, primarily in a Development environment in multiple biopharmaceutical companies based in the US and Europe. He has been a leader and driving force in improving the Development and Regulatory environments in several key markets around the world.

Dr. Butler has also been active for many years in advancing Asian-Western development/regulatory single programs. His industry experience includes R&D leadership team membership at pharmaceutical vanguards AstraZeneca and Novartis, where he also headed the global Regulatory Affairs teams.

He has managed sizable budgets and teams of people from various cultures, and has a long and distinguished record of insightful business management and successful regulatory approvals across all major therapeutic areas.

Dr. Butler holds his doctorate from the University of Manchester, UK. He has chaired and spoken at many global healthcare industry and regulatory authority meetings. Dr. Butler has also been a long time valued member of the Regulatory Advisory Board of the Centre for Medicines Research; he has chaired the European Licensing section of the UK government/industry sponsored competitiveness initiative (PICTF); and has participated in the UK government’s Supervisory Board for the MCA.

He has been on the boards of several non-profits and for-profit companies, and is a senior advisor to the non-profit US IVB (Initiative for Value-Based Preventive Medicine).